Literature DB >> 19618351

The "RTR" medical response system for nuclear and radiological mass-casualty incidents: a functional TRiage-TReatment-TRansport medical response model.

Chad M Hrdina1, C Norman Coleman, Sandy Bogucki, Judith L Bader, Robert E Hayhurst, Joseph D Forsha, David Marcozzi, Kevin Yeskey, Ann R Knebel.   

Abstract

Developing a mass-casualty medical response to the detonation of an improvised nuclear device (IND) or large radiological dispersal device (RDD) requires unique advanced planning due to the potential magnitude of the event, lack of warning, and radiation hazards. In order for medical care and resources to be collocated and matched to the requirements, a [US] Federal interagency medical response-planning group has developed a conceptual approach for responding to such nuclear and radiological incidents. The "RTR" system (comprising Radiation-specific TRiage, TReatment, TRansport sites) is designed to support medical care following a nuclear incident. Its purpose is to characterize, organize, and efficiently deploy appropriate materiel and personnel assets as close as physically possible to various categories of victims while preserving the safety of responders. The RTR system is not a medical triage system for individual patients. After an incident is characterized and safe perimeters are established, RTR sites should be determined in real-time that are based on the extent of destruction, environmental factors, residual radiation, available infrastructure, and transportation routes. Such RTR sites are divided into three types depending on their physical/situational relationship to the incident. The RTR1 sites are near the epicenter with residual radiation and include victims with blast injuries and other major traumatic injuries including radiation exposure; RTR2 sites are situated in relationship to the plume with varying amounts of residual radiation present, with most victims being ambulatory; and RTR3 sites are collection and transport sites with minimal or no radiation present or exposure risk and a victim population with a potential variety of injuries or radiation exposures. Medical Care sites are predetermined sites at which definitive medical care is given to those in immediate need of care. They include local/regional hospitals, medical centers, other sites such as nursing homes and outpatient clinics, nationwide expert medical centers (such as cancer or burn centers), and possible alternate care facilities such as Federal Medical Stations. Assembly Centers for displaced or evacuating persons are predetermined and spontaneous sites safely outside of the perimeter of the incident, for use by those who need no immediate medical attention or only minor assistance. Decontamination requirements are important considerations for all RTR, Medical Care, and Assembly Center sites and transport vehicles. The US Department of Health and Human Services is working on a long-term project to generate a database for potential medical care sites and assembly centers so that information is immediately available should an incident occur.

Entities:  

Mesh:

Year:  2009        PMID: 19618351     DOI: 10.1017/s1049023x00006774

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  14 in total

Review 1.  A review of the literature on the validity of mass casualty triage systems with a focus on chemical exposures.

Authors:  Joan M Culley; Erik Svendsen
Journal:  Am J Disaster Med       Date:  2014

2.  Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE).

Authors:  C Norman Coleman; Judith L Bader; John F Koerner; Chad Hrdina; Kenneth D Cliffer; John L Hick; James J James; Monique K Mansoura; Alicia A Livinski; Scott V Nystrom; Andrea DiCarlo-Cohen; Maria Julia Marinissen; Lynne Wathen; Jessica M Appler; Brooke Buddemeier; Rocco Casagrande; Derek Estes; Patrick Byrne; Edward M Kennedy; Ann A Jakubowski; Cullen Case; David M Weinstock; Nicholas Dainiak; Dan Hanfling; Andrew L Garrett; Natalie N Grant; Daniel Dodgen; Irwin Redlener; Thomas F MacKAY; Meghan Treber; Mary J Homer; Tammy P Taylor; Aubrey Miller; George Korch; Richard Hatchett
Journal:  Disaster Med Public Health Prep       Date:  2019-12       Impact factor: 1.385

3.  UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS.

Authors:  Mary J Homer; Robert Raulli; Andrea L DiCarlo-Cohen; John Esker; Chad Hrdina; Bert W Maidment; Brian Moyer; Carmen Rios; Francesca Macchiarini; Pataje G Prasanna; Lynne Wathen
Journal:  Radiat Prot Dosimetry       Date:  2016-09-02       Impact factor: 0.972

4.  Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise.

Authors:  C Norman Coleman; Julie M Sullivan; Judith L Bader; Paula Murrain-Hill; John F Koerner; Andrew L Garrett; David M Weinstock; Cullen Case; Chad Hrdina; Steven A Adams; Robert C Whitcomb; Ellie Graeden; Robert Shankman; Timothy Lant; Bert W Maidment; Richard C Hatchett
Journal:  Health Phys       Date:  2015-02       Impact factor: 1.316

5.  Scientific research and product development in the United States to address injuries from a radiation public health emergency.

Authors:  Andrea L DiCarlo
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

6.  Biodosimetry: Medicine, Science, and Systems to Support the Medical Decision-Maker Following a Large Scale Nuclear or Radiation Incident.

Authors:  C Norman Coleman; John F Koerner
Journal:  Radiat Prot Dosimetry       Date:  2016-07-29       Impact factor: 0.954

7.  Triage, monitoring, and treatment of mass casualty events involving chemical, biological, radiological, or nuclear agents.

Authors:  Aruna C Ramesh; S Kumar
Journal:  J Pharm Bioallied Sci       Date:  2010-07

8.  Civilian nuclear incidents: An overview of historical, medical, and scientific aspects.

Authors:  Yuri Rojavin; Mark J Seamon; Ravi S Tripathi; Thomas J Papadimos; Sagar Galwankar; Nicholas Kman; James Cipolla; Michael D Grossman; Raffaele Marchigiani; Stanislaw P A Stawicki
Journal:  J Emerg Trauma Shock       Date:  2011-04

9.  Meeting Report: A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome.

Authors:  Lanyn P Taliaferro; David R Cassatt; Zulmarie Perez Horta; Merriline M Satyamitra
Journal:  Radiat Res       Date:  2021-10-01       Impact factor: 2.841

10.  Fibrinogen-Coated Albumin Nanospheres Prevent Thrombocytopenia-Related Bleeding.

Authors:  Anthony D Sung; Richard C Yen; Yiqun Jiao; Alyssa Bernanke; Deborah A Lewis; Sara E Miller; Zhiguo Li; Joel R Ross; Alexandra Artica; Sadhna Piryani; Dunhua Zhou; Yang Liu; Tuan Vo-Dinh; Maureane Hoffman; Thomas L Ortel; Nelson J Chao; Benny J Chen
Journal:  Radiat Res       Date:  2020-08-01       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.